Consulting

China Health Policy Executive Briefing

Strategic Foresight for Commercial and Access Decision-Makers

A quarterly health policy intelligence service—purpose-built for senior life sciences leaders making portfolio, pricing, and go-to-market decisions that must reflect China’s fast-evolving access and payment environment.

We surface what matters—policy shifts with commercial consequence—and translate them into client-specific insights aligned to portfolio priorities, strategic focus areas, and team roles.

Each engagement includes a tailored quarterly readout—highlighting the implications that matter most to your organization—plus a team subscription to Access360, our platform for real-time policy updates and capability building through deep-dive articles and executive courses.

---

Bespoke Projects

We also deliver tailored solutions to help life sciences firms apply policy insights to product-level decisions, access strategies, and broader commercial planning.